Literature DB >> 2989605

Cohort study of internal malignancy in genetic hemochromatosis and other chronic nonalcoholic liver diseases.

R A Bradbear, C Bain, V Siskind, F D Schofield, S Webb, E M Axelsen, J W Halliday, M L Bassett, L W Powell.   

Abstract

The risk of hepatocellular carcinoma (HCC) and other internal malignancies was examined in patients with genetic hemochromatosis (GH) by following 208 patients from the time of diagnosis to June 1983 and by comparing the numbers of cancers they developed with expected values constructed from cancer registry incidence data by means of actuarial methods. In addition, cancers occurring in a comparison group of 148 subjects with other chronic nonalcoholic liver diseases (CLD) were determined. Among the GH group, 16 new cases of HCC occurred subsequent to the diagnosis of GH, together with 8 other malignancies. The 16 cases of HCC reflect a 200-fold excess risk, which from all indications represents the first quantitation of the risk of this tumor in GH. There appears to be no increased risk of other malignancies in this disease. Among the CLD group only 1 HCC and 1 other malignancy occurred.

Entities:  

Mesh:

Year:  1985        PMID: 2989605

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  37 in total

Review 1.  Hereditary (primary) haemochromatosis.

Authors:  N D Finlayson
Journal:  BMJ       Date:  1990 Aug 18-25

Review 2.  Modulation of hepcidin to treat iron deregulation: potential clinical applications.

Authors:  Nicole L Blanchette; David H Manz; Frank M Torti; Suzy V Torti
Journal:  Expert Rev Hematol       Date:  2015-12-15       Impact factor: 2.929

3.  Oxidative DNA damage and its repair in rat spleen following subchronic exposure to aniline.

Authors:  Huaxian Ma; Jianling Wang; Sherif Z Abdel-Rahman; Paul J Boor; M Firoze Khan
Journal:  Toxicol Appl Pharmacol       Date:  2008-08-22       Impact factor: 4.219

Review 4.  Non-viral causes of hepatocellular carcinoma.

Authors:  Wojciech Blonski; David S Kotlyar; Kimberly A Forde
Journal:  World J Gastroenterol       Date:  2010-08-07       Impact factor: 5.742

Review 5.  Iron toxicity and chelation therapy.

Authors:  Robert S Britton; Katherine L Leicester; Bruce R Bacon
Journal:  Int J Hematol       Date:  2002-10       Impact factor: 2.490

6.  Up-regulation of heme oxygenase-1 in rat spleen after aniline exposure.

Authors:  Jianling Wang; Huaxian Ma; Paul J Boor; V M Sadagopa Ramanujam; G A S Ansari; M Firoze Khan
Journal:  Free Radic Biol Med       Date:  2009-12-04       Impact factor: 7.376

Review 7.  Hepatic iron overload and hepatocellular carcinoma.

Authors:  Michael C Kew
Journal:  Liver Cancer       Date:  2014-03       Impact factor: 11.740

8.  Lack of association between HFE gene mutations and hepatocellular carcinoma in patients with cirrhosis.

Authors:  V Boige; L Castéra; N de Roux; N Ganne-Carrié; B Ducot; G Pelletier; M Beaugrand; C Buffet
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

Review 9.  Roles of iron in neoplasia. Promotion, prevention, and therapy.

Authors:  E D Weinberg
Journal:  Biol Trace Elem Res       Date:  1992-08       Impact factor: 3.738

Review 10.  Iron and cancer: more ore to be mined.

Authors:  Suzy V Torti; Frank M Torti
Journal:  Nat Rev Cancer       Date:  2013-04-18       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.